Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia
JACC: Asia · 2026-01 · 6 (1) · 16-23
DOI: 10.1016/j.jacasi.2025.07.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Asia, 2026-01. Verfasst von Kent Chak-Yu So und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institutes of…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Tricuspid regurgitation (TR) causes significant morbidity. Transcatheter edge-to-edge repair (TEER) has been proven effective in relieving TR symptoms. Access to tricuspid TEER and the associated experience are limited in Asia. OBJECTIVES: This study aimed to summarize the initial experience with the tricuspid TEER system (Abbott) in Asia. METHODS: Patients undergoing tricuspid TEER (Abbott) from 2017 to 2024 were enrolled from 4 centers in Asia. The primary endpoint was device success (TR ≤moderate) at 30 days. Secondary endpoints included inpatient complications, 30-day NYHA functional class, and 30-day major adverse events. Risk factors for 30-day device success were identified. RESULTS: A total of 106 patients were included, with a mean age of 76.1 ± 10 years, and 88.7% (n = 94 of 106) had atrial fibrillation. Most TR cases treated were functional (88.7% [n = 94 of 106]), with over half classified as massive or torrential (56.6% [n = 60 of 106]). Tricuspid TEER was performed using off-label MitraClip in 22.6% (n = 24), while the remaining 77.4% (n = 82) utilized TriClip. Combined procedures (with mitral TEER and others) were common (47.2% [n = 50 of 106]). At 30 days, 74.0% (n = 77 of 104) achieved device success (TR ≤moderate), and 95.2% (n = 99 of 104) experienced at least a 1-grade TR reduction. Additionally, 96.2% (n = 100 of 104) were NYHA functional class I/II, and major adverse events were 1.9% (n = 2 of 106) at 30 days. Baseline nontorrential TR and increased clinical experience (second half of cases) were associated with 30-day device success (P = 0.010 and P = 0.044, respectively). CONCLUSIONS: The early experience with tricuspid TEER in Asia is promising, demonstrating a reasonable device success rate and a high safety profile. Clinical experience is associated with improved device success.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institutes of Health Science, Prince of Wales Hospital, The Chinese University of H…
- Division of Cardiology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Cardiovascular Research Center, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Heart and Vascular Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Central Health Medical Practice, Hong Kong SAR, China. Electronic address: yylam@me.com.
Zitieren
APA
So, K. C., Meemook, K., Xu, J., Chang, C. C., Ngernsritrakul, T., Leelasithorn, S., Lee, C. W., Lai, A., Kam, K. K., Yan, B. P., Lee, A. P., Sung, A. S. H., & Lam, Y. Y. (2026). Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia. JACC: Asia, 6(1), 16-23. https://doi.org/10.1016/j.jacasi.2025.07.024
Vancouver
So KC, Meemook K, Xu J, Chang CC, Ngernsritrakul T, Leelasithorn S, et al. Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia. JACC: Asia. 2026;6(1):16-23. doi:10.1016/j.jacasi.2025.07.024
BibTeX
@article{So2026,
author = {So, Kent Chak-Yu and Meemook, Krissada and Xu, Jianqiang and Chang, Chun-Chin and Ngernsritrakul, Tawai and Leelasithorn, Surakiat and Lee, Ching-Wei and Lai, Angel and Kam, Kevin Ka-Ho and Yan, Bryan P and Lee, Alex Pui-Wai and Sung, Adam S H and Lam, Yat-Yin},
title = {Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia},
journal = {JACC: Asia},
year = {2026},
volume = {6},
number = {1},
pages = {16--23},
doi = {10.1016/j.jacasi.2025.07.024}
}
EUVIMED